Accordingly, Ebrahimi et al. identified a significant increase in AKT expression in GCs of a PCOS mouse model with AST treatment, confirming decreased intracellular ROS and an insignificant reduction in apoptosis [18]. The gene discussed is AKT1; the disease is polycystic ovary syndrome.